Strongyloidiasis: A diagnosis more common than we think

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 7, 2012, Pages 860-862

  Koczka, Charles Philip ^a   Hindy, Pierre ^a   Goodman, Adam ^a   Gress, Frank ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

parasitic infection; Strongyloides; strongyloidiasis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CASE STUDY; CLINICAL ARTICLE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; COUGHING; DIARRHEA; DUODENUM BIOPSY; DUODENUM ULCER; ENDOSCOPY; EOSINOPHILIA; FECES ANALYSIS; FEMALE; GASTRITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAUNDICE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH BIOPSY; STOMACH ULCER; STRONGYLOIDIASIS; UNITED STATES; URTICARIA; VOMITING; WEIGHT REDUCTION;

ABDOMINAL PAIN; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; DIARRHEA; FECES; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; VOMITING; WEIGHT LOSS;

EID: 84862188071     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283543ea0     Document Type: Article

References (19)

1. Concha R, Harrington W, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcomes. J Clin Gastroenterol 2005; 39:203-211.
2. Brodine SK, Thomas A, Huang R, Harbertson J, Mehta S, Leake J, et al. Community based parasitic screening and treatment of Sudanese refugees: application and assessment of Centers for Disease Control guidelines. Am J Trop Med Hyg 2009; 80:425-430.
3. Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004; 26:487-497.
4. Murphy EL, Figueroa JP, Gibbs W, Holding-Cobham M, Cranston B, Malley K, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991; 133: 1114-1124.
5. Stewart DM, Ramanathan R, Mahanty S, Fedorko DP, Janik JE, Morris JC. Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma. Acta Haematol 2011; 126:63-67.
6. Grove DI. Strongyloidiasis in allied ex-prisoners of war in south-east Asia. Br Med J 1980; 280:598-601.
7. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33:1040-1047.
8. Gotuzzo E, Angelica T, Alvarez H, Tello R, Infante R, Watts DM, Freedman DO. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 1999; 60:146-149.
9. Meine GC, Dietz J, Rocha M, Mattos T, de Souza AR, Conteletti FR. Atypical gastric presentation of strongyloidiasis in HIV-infected patient - case report. Dig Liver Dis 2004; 36:760-762.
10. Somani SK, Goyal R, Awasthi G. Duodenal mucosal nodularity in Strongyloides stercoralis infection. Trop Gastroenterol 2009; 30:47-48.
11. Juchems MS, Niess JH, Leder G, Barth TF, Adler G, Brambs HJ,Wagner M. Strongyloides stercoralis: a rare cause of obstructive duodenal stenosis. Digestion 2008; 77 (3-4):141-144.
12. Hizawa K, Iida M, Aoyagi K, Kimura Y, Eguchi K, Fujishima M. Early detection of strongyloidiasis using endoscopic duodenal biopsy: report of a case. J Clin Gastroenterol 1996; 22:157-159.
13. Csermely L, Jaafar H, Kristensen J, Castella A, Gorka W, Chebli AA, et al. Strongyloides hyper-infection causing life-threatening gastrointestinal bleeding. World J Gastroenterol 2006; 12:6401-6404.
14. Kishimoto K, Hokama A, Hirata T, Ihama Y, Nakamoto M, Kinjo N, et al. Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. World J Gastroenterol 2008; 14:1768-1773.
15. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother 2007; 41: 1992-2001.
16. Ganesh S, Cruz RJ Jr. Strongyloidiasis: a multifaceted disease. Gastroenterol Hepatol (N Y) 2011; 7:194-196.
17. Shikiya K, Zaha O, Niimura S, Uehara T, Ohshiro J, Kinjo F, et al. Clinical study on ivermectin against 125 strongyloidiasis patients. Kansenshogaku Zasshi 1994; 68:13-20.
18. Sato Y, Shiroma Y, Kiyuna S, Toma H, Kobayashi J. Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan. Trans R Soc Trop Med Hyg 1994; 88:59.
19. Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K. Reduced efficacy of treatment of strongyloidiasis in HTLV-1 carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin Exp Immunol 2002; 127:354-359.